Pregnancy and liver disease

Current Gastroenterology Reports

Volumn 10, Issue 1, 2008, Pages 15-21

  Su, Grace L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BILE ACID; COLESTYRAMINE; CORTICOSTEROID; DEXAMETHASONE; HEPATITIS B ANTIBODY; LAMIVUDINE; NUCLEOSIDE ANALOG; PLACEBO; RECOMBINANT HEPATITIS B VACCINE; S ADENOSYLMETHIONINE; URSODEOXYCHOLIC ACID;

ACUTE DISEASE; BED REST; BILE ACID BLOOD LEVEL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DELIVERY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DRUG EFFICACY; ETHNICITY; FATTY LIVER; FEMALE; FETUS OUTCOME; GENETIC ANALYSIS; HELLP SYNDROME; HEPATITIS B; HUMAN; HYPEREMESIS GRAVIDARUM; INTRAHEPATIC CHOLESTASIS; LIVER DISEASE; MOLECULAR GENETICS; MONOTHERAPY; MORBIDITY; MORTALITY; PATHOGENESIS; PREGNANCY; PREMATURE LABOR; PRURITUS; REHYDRATION; REVIEW; VIRUS LOAD; VIRUS TRANSMISSION; PREGNANCY COMPLICATION;

ACUTE DISEASE; FATTY LIVER; FEMALE; HELLP SYNDROME; HUMANS; LIVER DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 51549105993     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0004-0     Document Type: Review

References (38)

1. Dodds L, Fell DB, Joseph KS, et al.: Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol 2006, 107: 285-292.
2. Lee RH, Goodwin TM, Greenspoon J, et al.: The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 2006, 26: 527-532.
3. Schneider G, Paus TC, Kullak-Ublick GA, et al.: Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 2007, 45: 150-158.
4. Floreani A, Carderi I, Paternoster D, et al.: Intrahepatic cholestasis of pregnancy: Three novel MDR3 gene mutations. Aliment Pharmacol Ther 2006, 23: 1649-1653.
5. Poupon R: Intrahepatic cholestasiF of pregnancy: from bedside to bench to bedside. Liver Int 2005, 25: 467-468.
6. Beuers U, Pusl T: Intrahepatic cholestasis of pregnancy - a heterogeneous group of pregnancy-related disorders? Hepatology 2006, 43: 647-649.
7. Reyes H, Zapata R, Hernandez I, et al.: Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy? Hepatology 2006, 43: 715-722.
8. Glantz A, Marschall HU, Mattsson LA: Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004, 40: 467-474.
9. Binder T, Salaj P, Zima T, et al.: Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006, 34: 383-391.
10. Glantz A, Marschall HU, Lammert F, et al.: Intrahepatic cholestasis of pregnancy: A randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005, 42: 1399-1405.
11. Sentilhes L, Verspyck E, Roman H, et al.: Intrahepatic cholestasis of pregnancy and bile acid levels. Hepatology 2005, 42: 737-738; author reply 738.
12. Sentilhes L, Verspyck E, Pia P, et al.: Fetal death in a patient with intrahepatic cholestasis of pregnancy. Obstet Gynecol 2006, 107: 458-460.
13. Alsulyman OM, Ouzounian JG, Ames-Castro M, et al.: Intrahepatic cholestasis of pregnancy: Perinatal outcome associated with expectant management. Am J Obstet Gynecol 1996, 175: 957-960.
14. Kondrackiene J, Beuers U, Kupcinskas L: Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005, 129: 894-901.
15. Weinstein L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142: 159-167.
16. Sibai BM, Ramadan MK, Usta I, et al.: Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993, 169: 1000-1006.
17. Guntupalli SR, Steingrub A: Hepatic disease and pregnancy: an overview of diagnosis and management. Crit Care Med 2005, 33: S332-S339.
18. Martin JN, Jr, Rose CH, Briery CM: Understanding and managing HELLP syndrome: The integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 2006, 195: 914-934.
19. Sibai BM, Taslimi MM, el-Nazer A, et al.: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986, 155: 501-509.
20. O'Brien JM, Barton JR: Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 2005, 48: 460-477.
21. Martin JN, Jr, Rinehart BK, May WL, et al.: The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999, 180: 1373-1384.
22. Magann EF, Bass D, Chauhan SP, et al.: Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994, 171: 1148-1153.
23. Magann EF, Perry KG, Jr, Meydrech EF, et al.: Postpartum corticosteroids: Accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994, 171: 1154-1158.
24. Isler CM, Barrilleaux PS, Magann EF, et al.: A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2001, 184: 1332-1337, discussion 1337-1339.
25. Tompkins MJ, Thiagarajah S: HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: The benefit of corticosteroids. Am J Obstet Gynecol 1999, 181: 304-309.
26. Martin JN, Jr, Files JC, Blake PG, et al.: Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1995, 172: 1107-1125, discussion 1125-1127.
27. Martin JN, Jr, Perry KG, Jr, Roberts WE, et al.: Plasma exchange for preeclampsia: III. Immediate peripartal utilization for selected patients with HELLP syndrome. J Clin Apher 1994, 9: 162-165.
28. Smith LG, Jr, Moise KJ, Jr, Dildy GA III, et al.: Spontaneous rupture of liver during pregnancy: Current therapy. Obstet Gynecol 1991, 77: 171-175.
29. Ibdah JA, Bennett MJ, Rinaldo P, et al.: A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999, 340: 1723-1731.
30. Ibdah JA: Acute fatty liveA of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006, 12: 7397-7404.
31. Browning MF, Levy HL, Wilkins-Haug LE, et al.: Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006, 107: 115-120.
32. Chang MH: Hepatitis B virus infection. Semin Fetal Neonatal Med 2007, 12: 160-167.
33. Ngui SL, Andrews NJ, Underhill GS, et al.: Failed postnatal immunoprophylaxis for hepatitis B: Characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998, 27: 100-106.
34. del Canho R, Grosheide PM, Mazel JA, et al.: Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity. Vaccine 1997, 15: 1624-1630.
35. van Zonneveld M, van Nunen AB, Niesters HG, et al.: Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003, 10: 294-297.
36. Su GG, Pan KH, Zhao NF, et al.: Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004, 10: 910-912.
37. Xu WM, Cui YT, Wang L, et al.: Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B: A multicentre, randomised, double blind, placebo-controlled study [abstract 246]. Hepatology 2004, 40: 272A.
38. Xiao XM, Li AZ, Chen X, et al.: Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007, 96: 167-170.